Handelsavisen
prelaunch
Companies Healthcare 048870.KQ
04
048870.KQ KOSDAQ Medical Equipment, Supplies & Distribution

048870.Kq

$1 938,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
16,8 %
ROE
1,4 %
Net margin
2,7 %
Debt / equity
0,17
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.

Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
1,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 048870.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 048870.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily generating revenue through the production and distribution of medical equipment and supplies.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with a current ratio of 3.56, indicating that it has sufficient current assets to cover its current liabilities more than three times over. However, the liquidity risk is assessed as medium, suggesting that while the company is not in immediate distress, it may face challenges in maintaining this level under stress conditions. The debt-to-equity ratio of 0.17 indicates a conservative capital structure, with a relatively low proportion of debt compared to equity.

    In terms of profitability, the company's return on equity (ROE) is 1.42%, and its return on assets (ROA) is 0.89%. These figures are below the typical thresholds for strong performance in the healthcare equipment and supplies industry, suggesting that the company is not generating returns at a level that would be considered robust by industry standards. The operating income of 19,029,731,550 KRW and net income of 3,011,341,240 KRW indicate that the company is profitable, but the margins are relatively thin.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification may expose the company to higher risk if demand in its primary market fluctuates. The company's capital expenditure of -5,370,436,900 KRW suggests that it is not investing heavily in new assets, which may limit its ability to grow or modernize its operations.

    Looking ahead, the company's growth trajectory is expected to be modest, with no significant revenue growth projected in the next fiscal year. The company's free cash flow of 9,659,911,640 KRW provides some flexibility for reinvestment or shareholder returns, but the lack of capital expenditure may constrain future growth. The company's operating cash flow of 14,777,578,740 KRW supports its current operations and debt obligations, but it is not generating excess cash for aggressive expansion.

    The risk assessment indicates that the company faces a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to manage its cash flow carefully to avoid liquidity issues. The dilution risk is low, indicating that the company is not expected to issue a significant number of new shares in the near term, which is a positive sign for existing shareholders.

    Recent events, as disclosed in the company's financial statements, include a focus on maintaining operational efficiency and managing debt levels. The company has not reported any major new product launches or strategic acquisitions in the latest reporting period, which may indicate a conservative approach to growth.

    Key takeaways
    • The company has a strong current ratio of 3.56, indicating good short-term liquidity.
    • The company's ROE of 1.42% and ROA of 0.89% are below industry norms, suggesting suboptimal returns.
    • The company's revenue is concentrated in a single business segment, increasing exposure to market fluctuations.
    • The company's capital expenditure is negative, indicating a lack of investment in new assets.
    • The company's liquidity risk is assessed as medium, and its dilution risk is low.
    • The company's free cash flow of 9,659,911,640 KRW provides some flexibility for reinvestment or shareholder returns.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1 938,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $211.51B
    Net cash
    -$35.90B
    Current ratio
    3.6
    Debt / equity
    0.2
    ROA
    0.9%
    ROE
    1.4%
    Cash conversion
    491.0%
    CapEx / revenue
    -4.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin16,8 %Above P75
    Net Margin2,7 %Below median
    ROE1,4 %Below median
    Capex / Rev-4,8 %Above median
    D/E0,17Above median
    Cash Conv4,91Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 048870.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    048870.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage